Where smart money is
flowing right now.

8 public government databases. Translated into plain English by AI. Updated every 4 hours.

Join the Beta — first 2 months completely free
20 of 20 founding spots remaining · card saved, not charged for 60 days
Claim your spot

Live sector flow map

Technology
+1.00
Healthcare
+1.00
Defense
+1.00
Energy
+0.00
Finance
+0.00
Consumer
+0.00
Industrials
+0.00

Pro users see all 11 sector signals in real time. Upgrade →

Latest filings

N/AFDA

FDA approved Farxiga to reduce heart-failure risks, and AstraZeneca AB makes it.

N/AFDA

FDA approved Aurobindo Pharma’s tofacitinib extended-release tablets, 11 mg, a generic version of Xeljanz XR.

N/AFDA

FDA approved Steglujan, a pill for adults with type 2 diabetes, made by Merck Sharp & Dohme LLC.

N/AFDA

The FDA approved Steglatro (ertugliflozin) to help control blood sugar in adults with type 2 diabetes, and it is made by Merck Sharp & Dohme.

Powered by 8 public government databases

SEC EDGARCongressional STOCK ActUSASpending.govSEC 13FCFTCFINRAFDA PDUFAYour Documents